Skip to main content

Articles

Page 2 of 19

  1. The shift from prescription to illicit drugs involved in drug poisoning deaths raises questions about the current utility of prescription drug monitoring program (PDMP) data to inform drug poisoning (overdose)...

    Authors: Patricia R. Freeman, Jana McAninch, Nabarun Dasgupta, Douglas R. Oyler, Krassimir Slavov, Candice Collins, Sarah Hargrove, Edward Freeman, Dustin Miracle and Svetla Slavova
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:53
  2. Nicotine dependence, factors associated with dependence, and self-reported side effects among people who use e-cigarettes are scarce in developing countries.

    Authors: Chandrashekhar T. Sreeramareddy, Sameeha Misriya Shroff and Shilpa Gunjal
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:51
  3. Electronic cigarette use has surged internationally in recent years, with numerous countries noting an uptick in users. Despite this, the portrayal of e-cigarette usage in African news remains unclear.

    Authors: Chimwemwe Ngoma and Yusuff Adebayo Adebisi
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:50
  4. This study examines the functions and purposes of the International Center for Alcohol Policies (ICAP) book series, published by Routledge between 1998 and 2010. The books were authored by invited academics, I...

    Authors: Andrew Bartlett and Jim McCambridge
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:49
  5. Authors: Magdalena Ydreborg, Emil Lundström, Rosanna Kolleby, Sofia Lexén, Elena Pizarro, Jessica Lindgren, Rune Wejstål and Simon B. Larsson
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:48

    The original article was published in Substance Abuse Treatment, Prevention, and Policy 2023 18:17

  6. Physical diseases represent a significant burden for opioid agonist treatment (OAT) patients. This study described physical morbidity in two national cohorts of OAT patients focusing on gender differences.

    Authors: Gabriela Rolová, Desiree Eide, Roman Gabrhelík, Ingvild Odsbu, Thomas Clausen and Svetlana Skurtveit
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:47
  7. Data on driving under the influence of alcohol (DUIA) are not always available, accurate, or reliable, making it difficult to study the effects of alcohol policies on road traffic outcomes. The objectives of o...

    Authors: Pablo Martínez, Junon Joseph and José Ignacio Nazif-Munoz
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:46
  8. While person-centered care (PCC) includes multiple domains, residential substance use disorder (SUD) treatment clients may value certain domains over others. We sought to identify the PCC domains most valued b...

    Authors: Barbara Andraka-Christou, Danielle N. Atkins, Morgan C. Shields, Olivia K. Golan, Rachel Totaram, Kendall Cortelyou, Glenn W. Lambie and Olena Mazurenko
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:45
  9. Substance use constitutes a major public health issue especially among adolescents as it has associated adverse behavioural, health, social and economic outcomes. However, there is a paucity of comprehensive e...

    Authors: Nuworza Kugbey
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:44
  10. We investigated the interaction between arrests for technical violations vs. receiving new charges with receiving community-based methadone treatment on time-to reincarceration (TTR) in a cohort of men with op...

    Authors: Phillip Marotta, Alissa Hass, Adam Viera, Molly Doernberg, Russell Barbour, Lauretta E. Grau and Robert Heimer
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:43
  11. Encephalopathy can occur from a non-fatal toxic drug event (overdose) which results in a partial or complete loss of oxygen to the brain, or due to long-term substance use issues. It can be categorized as a no...

    Authors: Chloé G. Xavier, Margot Kuo, Roshni Desai, Heather Palis, Gemma Regan, Bin Zhao, Jessica Moe, Frank X. Scheuermeyer, Wen Qi Gan, Soha Sabeti, Louise Meilleur, Jane A. Buxton and Amanda K. Slaunwhite
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:42
  12. The high rate of treatment failure is a common problem in the treatment of methamphetamine use. Therefore, the aim of this research is to identify the most common causes of relapse in methamphetamine users.

    Authors: Faezeh Kaviyani, Mohammad Khorrami, Hamid Heydari and Malihe Namvar
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:41
  13. Much remains unknown about the dynamics of substitute behaviors during addiction recovery among persons attending recovery support groups. Insight into the nature, motives for, and course of substitute behavio...

    Authors: Deborah Louise Sinclair, Steve Sussman, Shazly Savahl, Maria Florence and Wouter Vanderplasschen
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:40
  14. Khat (Catha edulis) is a plant commonly found in the horn of Africa whose leaves are chewed for their psycho-stimulant effects. Several studies have demonstrated the association between khat use and mental health...

    Authors: Amanti Baru Olani, Mulusew Gerbaba, Masrie Getnet, Matiwos Soboka and Tom Decorte
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:39
  15. The association of traumatic experiences with problematic alcohol use has been described, but data on possible mediation effects of mental distress are sparse. We examined whether mental ill-health mediated th...

    Authors: Kim A. Nguyen, Bronwyn Myers, Naeemah Abrahams, Rachel Jewkes, Shibe Mhlongo, Soraya Seedat, Carl Lombard, Claudia Garcia-Moreno, Esnat Chirwa, Andre P. Kengne and Nasheeta Peer
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:38
  16. Long-acting injectable buprenorphine (LAIB) is a new treatment for opioid use disorder that has been introduced against an international policy backdrop of recovery and person-centred care. This paper explores...

    Authors: Joanne Neale, Stephen Parkin and John Strang
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:37
  17. In 2018, Canada legalized recreational cannabis use with the purpose of protecting youth and restricting access. However, concerns have been raised that this objective has not been met as rates of cannabis use...

    Authors: Toula Kourgiantakis, Eunjung Lee, A. Kumsal Tekirdag Kosar, Christine Tait, Carrie K.Y. Lau, Sandra McNeil, Shelley Craig, Rachelle Ashcroft, Charmaine C. Williams, Abby L. Goldstein, Uppala Chandrasekera, Deepy Sur and J. L. Henderson
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:36
  18. Cannabis marketing exposure via social media may impact use in youth and young adults. Most states with recreational cannabis lack policies regarding social media-based marketing. Thus, we examined such polici...

    Authors: Carla J. Berg, Cassidy R. LoParco, Yuxian Cui, Alexandria Pannell, Grace Kong, Lynniah Griffith, Katelyn F. Romm, Y. Tony Yang, Yan Wang and Patricia A. Cavazos-Rehg
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:35
  19. Smoking prevalence is high among people in substance use disorder (SUD) treatment, and program interventions to address smoking are often complex and lengthy. This cluster-randomized trial tested whether a bri...

    Authors: Joseph Guydish, Caravella McCuistian, Sindhushree Hosakote, Thao Le, Carmen L. Masson, Barbara K. Campbell and Kevin Delucchi
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:34
  20. Tobacco use remains a leading cause of premature death. To combat tobacco use, the Ministry of Health (MOH) improved access to smoking cessation clinics (SCCs) by developing fixed SCCs and mobile SCCs, which m...

    Authors: Sarah S. Monshi, Abdullah M. M. Alanazi, Ali M. Alzahrani, Abdulrhman A. Alzhrani, Turky J. Arbaein, Khulud K. Alharbi, Mansour Z. Alqahtani, Ali H. Alzahrani, Ahmed A. Elkhobby, Aljoharah M. Almazrou and Abdulmohsen H. Al-Zalabani
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:33
  21. In May 2022, Health Canada approved a three-year exemption from the Controlled Drugs and Substances Act decriminalizing possession of certain illegal substances for personal use among adults in the province of...

    Authors: Farihah Ali, Cayley Russell, Alissa Greer, Matthew Bonn, Daniel Werb and Jürgen Rehm
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:32
  22. People who use cannabis daily or near-daily vary considerably in their daily dosage and use frequency, impacting both experienced effects and adverse consequences. This study identified heavy cannabis user gro...

    Authors: Arturo Alvarez-Roldan, Teresa García-Muñoz, Juan F. Gamella, Iván Parra and Maria J. Duaso
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:31
  23. Medications for opioid use disorder (MOUD; methadone, buprenorphine, naltrexone) are the most effective treatments for OUD, and MOUD is protective against fatal overdoses. However, continued illegal drug use c...

    Authors: Jaclyn M. W. Hughto, Abigail Tapper, Sabrina S. Rapisarda, Thomas J. Stopka, Wilson R. Palacios, Patricia Case, Joseph Silcox, Patience Moyo and Traci C. Green
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:30
  24. The goal of this study was to (1) Describe the patient population of a newly implemented addiction medicine consult service (AMCS); (2) Evaluate referrals to community-based addiction support services and acut...

    Authors: Tara Leary, Natalie Aubin, David C. Marsh, Michael Roach, Paola Nikodem, Joseph M. Caswell, Bridget Irwin, Emma Pillsworth, Maureen Mclelland, Brad Long, Sastry Bhagavatula, Joseph K Eibl and Kristen A. Morin
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:29
  25. Parents with substance use disorders are highly stigmatized by multiple systems (e.g., healthcare, education, legal, social). As a result, they are more likely to experience discrimination and health inequities [

    Authors: Hannah S. Appleseth, Susette A. Moyers, Erica K. Crockett-Barbera, Micah Hartwell, Stephan Arndt and Julie M. Croff
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:28
  26. The increasing number of illicit drug toxicity deaths in British Columbia (BC) has led to calls for a regulated (pharmaceutical grade) supply of substances (“safe supply”). In order to inform safe supply recom...

    Authors: Ariba Kamal, Max Ferguson, Jessica C Xavier, Lisa Liu, Brittany Graham, Kurt Lock and Jane A. Buxton
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:27
  27. The Ask-Advise-Connect (AAC) approach can help primary care providers to increase the number of people who attempt to quit smoking and enrol into cessation counselling. We implemented AAC in Dutch general prac...

    Authors: Naomi A. van Westen-Lagerweij, Marc C. Willemsen, Esther A. Croes, Niels H. Chavannes and Eline Meijer
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:26
  28. Most people who inject drugs (PWIDs) suffer from severe fatigue, and chronic hepatitis C virus (HCV) infection may play a role in this. However, there is scarce evidence about interventions that alleviate fati...

    Authors: Jørn Henrik Vold, Fatemeh Chalabianloo, Else-Marie Løberg, Christer F. Aas, Aaron G. Lim, Peter Vickerman, Kjell Arne Johansson and Lars Thore Fadnes
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:25
  29. Opioid overdoses are a growing concern, particularly among people who inject drugs. Sweden, with a comparatively high proportion of drug-related mortality, introduced its first Take-Home Naloxone (THN) program...

    Authors: Elin Holmén, Anna Warnqvist and Martin Kåberg
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:24
  30. Rural areas in the United States (US) are ravaged by the opioid overdose epidemic. Oconee County, an entirely rural county in northwest South Carolina, is likewise severely affected. Lack of harm reduction and...

    Authors: Moonseong Heo, Taylor Beachler, Laksika B. Sivaraj, Hui-Lin Tsai, Ashlyn Chea, Avish Patel, Alain H. Litwin and T. Aaron Zeller
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:23
  31. “Kratom” commonly refers to the botanical Mitragyna speciosa, native to Southeast Asia, which is increasingly used globally for its unique pharmacological effects. Motives for using the whole plant material or kr...

    Authors: Katherine Hill, Stephen Gibson, Oliver Grundmann, Kirsten E. Smith, Jonathan Ballard and Corneliu N. Stanciu
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:21
  32. Smoking is a leading cause of avoidable deaths and attributable disability-adjusted life years globally. Yet, the determinants of smoking practices among women are understudied. This study assessed the determi...

    Authors: Daniel Chukwuemeka Ogbuabor, Alphonsus Ogbonna Ogbuabor and Matthew Chibunna Igwe
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:20
  33. Recreational use of anabolic-androgenic steroids (AAS) is a public health concern world-wide associated with a range of physical and psychological side effects. Still, people who use AAS tend to be reluctant t...

    Authors: Hans Christian Bordado Henriksen, Ingrid Amalia Havnes, Marie Lindvik Jørstad and Astrid Bjørnebekk
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:19
  34. Chronic infection with the hepatitis C virus (HCV) is common in people with former or current injection drug use. Among the patients in the opioid substitution treatment (OST) program in Gothenburg, Sweden, mo...

    Authors: Magdalena Ydreborg, Emil Lundström, Rosanna Kolleby, Sofia Lexén, Elena Pizarro, Jessica Lindgren, Rune Wejstål and Simon B. Larsson
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:17

    The Correction to this article has been published in Substance Abuse Treatment, Prevention, and Policy 2023 18:48

  35. Supervised consumption sites (SCS) and overdose prevention sites (OPS) have been increasingly implemented in response to the ongoing overdose epidemic in Canada. Although there has been a dramatic increase in ...

    Authors: Emili Gubskaya, Mary Clare Kennedy, Kanna Hayashi, Zishan Cui, M-J Milloy and Thomas Kerr
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:16
  36. Despite efficacy of medication for opioid use disorder, low-income, ethno-racial minoritized populations often experience poor opioid use disorder treatment outcomes. Peer recovery specialists, individuals wit...

    Authors: Mary B. Kleinman, Morgan S. Anvari, Valerie D. Bradley, Julia W. Felton, Annabelle M. Belcher, C. J. Seitz-Brown, Aaron D. Greenblatt, Dwayne Dean, Melanie Bennett and Jessica F. Magidson
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:15
  37. Rural and smaller urban settings in Canada are disproportionately impacted by the overdose crisis, highlighting the need for novel public health interventions within these jurisdictions. Tablet injectable opio...

    Authors: Geoff Bardwell, Jeanette M. Bowles, Manal Mansoor, Dan Werb and Thomas Kerr
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:14
  38. Young people are disproportionately more likely than other age groups to use substances. The rise in substance use and related harms, including overdose, during the Covid-19 pandemic has created a critical nee...

    Authors: Marika Monarque, Judith Sabetti and Manuela Ferrari
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:13

    The Correction to this article has been published in Substance Abuse Treatment, Prevention, and Policy 2023 18:22

  39. Promptly identifying individuals with addictive disorders reduces mortality and morbidity and improves quality of life. Although screening in primary care with the Screening, Brief Intervention and Referral Tr...

    Authors: Maxime Pautrat, Caroline Renard, Vincent Riffault, David Ciolfi, Agathe Edeline, Hervé Breton, Paul Brunault and Jean Pierre Lebeau
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:12
  40. Alcohol use disorder is prevalent globally and in Kenya, and is associated with significant health and socio-economic consequences. Despite this, available pharmacological treatment options are limited. Recent...

    Authors: Florence Jaguga, Philip Kirwa, Benson Gakinya, Imran Manji, Thomas Andale, Daniel Kinyanjui, Edith Kamaru Kwobah, Felicita Mwangi, Kituyi Werunga, Josephat Kerema, Charles Kwobah, Eunice Temet, Julia Songok and Wilson K. Aruasa
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:11
  41. Lower-risk substance use guidelines (LRSUGs) are an evidence-based harm reduction strategy used to provide information to people who use drugs so they can reduce harms associated with substance use.

    Authors: Zakkaery R. Moebes, Kiffer G. Card, Brett Koenig and Cecilia Benoit
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:10
  42. In recent years, emergency departments (EDs) across the nation have implemented peer recovery coach (PRC) services to support patients who use opioids. The majority of such interventions discussed in the liter...

    Authors: Dennis P. Watson, Peter Phalen, Spencer Medcalf, Sarah Messmer and Alan McGuire
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:9
  43. Hazardous alcohol use among people living with HIV is associated with poor outcomes and increased morbidity and mortality. Understanding the hazardous drinking experiences of people living with HIV is needed t...

    Authors: Jayne Lewis-Kulzer, Margaret Mburu, Sarah Obatsa, Julius Cheruiyot, Lorna Kiprono, Steve Brown, Cosmas Apaka, Hillary Koros, Winnie Muyindike, Edith Kamaru Kwobah, Lameck Diero, Maurice Aluda, Kara Wools-Kaloustian and Suzanne Goodrich
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:8
  44. Tobacco Harm Reduction (THR) offers a promising approach to addressing the significant burden of smoking in Afghanistan. Over three million Afghans smoke daily, making it a leading cause of preventable deaths ...

    Authors: Attaullah Ahmadi, Ali Rahimi, Mohammad Faisal Wardak, Hamidullah Ahmadi and Don Eliseo Lucero-Prisno III
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:7
  45. Women with perinatal substance problems experience a multitude of barriers to care. They have specific early intervention needs, they endure societal stigma, and both substances and mental health issues influe...

    Authors: Minna Sorsa, Maria Hohenthal, Miia Pikulinsky, Hanna Sellergren and Kaija Puura
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:6
  46. This study identified patient profiles in terms of their quality of outpatient care use, associated sociodemographic and clinical characteristics, and adverse outcomes based on frequent emergency department (E...

    Authors: Marie-Josée Fleury, Zhirong Cao, Guy Grenier and Christophe Huỳnh
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:5
  47. Medication for opioid use disorder (MOUD) is the gold standard treatment for opioid use disorder. Traditionally, “success” in MOUD treatment is measured in terms of program retention, adherence to MOUD, and ab...

    Authors: Megan K. Reed, Kelsey R. Smith, Francesca Ciocco, Richard W. Hass, Avery Lin Cox, Erin L. Kelly and Lara C. Weinstein
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:4
  48. Drug addiction is stigmatized, and this stigma contributes to poor outcomes for individuals with addiction. Researchers have argued that providing genetic explanations of addiction will reduce stigma, but ther...

    Authors: Hasan Siddiqui and M. D. Rutherford
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:3

Annual Journal Metrics

  • 2022 Citation Impact
    3.3 - 2-year Impact Factor
    3.5 - 5-year Impact Factor
    1.309 - SNIP (Source Normalized Impact per Paper)
    0.899 - SJR (SCImago Journal Rank)

    2023 Speed
    13 days submission to first editorial decision for all manuscripts (Median)
    81 days submission to accept (Median)

    2023 Usage 
    1,227,011 downloads
    1,434 Altmetric mentions